Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrotech (ASTC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Astrotech (ASTC) over the last 17 years, with Q3 2025 value amounting to $2.6 million.

  • Astrotech's Cash & Equivalents fell 5940.47% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 5940.47%. This contributed to the annual value of $3.1 million for FY2025, which is 7031.22% down from last year.
  • Latest data reveals that Astrotech reported Cash & Equivalents of $2.6 million as of Q3 2025, which was down 5940.47% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Astrotech's Cash & Equivalents registered a high of $35.9 million during Q2 2021, and its lowest value of $2.6 million during Q3 2025.
  • In the last 5 years, Astrotech's Cash & Equivalents had a median value of $13.6 million in 2023 and averaged $15.4 million.
  • As far as peak fluctuations go, Astrotech's Cash & Equivalents soared by 160804.1% in 2021, and later tumbled by 7151.23% in 2024.
  • Over the past 5 years, Astrotech's Cash & Equivalents (Quarter) stood at $30.2 million in 2021, then plummeted by 47.34% to $15.9 million in 2022, then plummeted by 30.17% to $11.1 million in 2023, then plummeted by 71.51% to $3.2 million in 2024, then fell by 16.29% to $2.6 million in 2025.
  • Its Cash & Equivalents stands at $2.6 million for Q3 2025, versus $3.1 million for Q2 2025 and $2.8 million for Q1 2025.